Cheonggukjang Fermented with Bacillus subtilis SCGB574 Ameliorates High Fat Diet-Deteriorated Large Intestinal Health in Rat Model

다국어 초록 (Multilingual Abstract)

Cheonggukjang is a traditional fermented food in Korea, which is known to exert beneficial effects on health. In this study, we evaluated the effects of cheonggukjang fermented by Bacillus subtilis SCGB 574 (B574) on high fat diet (HFD)-deteriorated large intestinal health. Rats were fed with HFD or HFD supplemented with 10.1% cheonggukjang (B574). Fecal microbiota was analyzed based on 16S rRNA gene sequences, and the fecal and serum metabolome were measured using GC-MS. Our results showed that SCGB574 intake significantly reduced body weight, restored tight junction components, and ameliorated inflammatory cell infiltration. SCGB574 also shifted gut microbiota by increasing the abundance of short chain fatty acid producers such as Alistipes and Flintibacter, although it decreased the abundance of Lactobacillus. Serum and fecal metabolome analyses showed significantly different metabolic profiles between the groups. The top five metabolites increased by SCGB574 were i) arginine biosynthesis, ii) alanine, aspartate, and glutamate metabolism; iii) starch and sucrose metabolism; iv) neomycin, kanamycin, and gentamicin biosynthesis; and v) galactose metabolism. These results showed that cheonggukjang fermented by SCGB574 ameliorates adverse effects of HFD through improving intestinal health.

참고문헌 (Reference)

• 1 Forster C, "Tight junctions and the modulation of barrier function in disease" 130 : 55-70, 2008
• 2 Untersmayr E, "The intestinal barrier dysfunction as driving factor of inflammaging" 14 : 949-, 2022
• 3 Winzell MS, "The high-fat diet-fed mouse : a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes" 53 (53): S215-S219, 2004
• 4 Markowiak-Kopec P, "The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome" 12 : 1107-, 2020
• 5 Van Klinken BJ, "Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis" 44 : 387-393, 1999
• 6 Huang C, "Soy isoflavones regulate lipid metabolism through an AKT/mTORC1pathway in Diet-Induced Obesity(DIO)male rats" 21 : 586-, 2016
• 7 Jeong DY, "Short-term fermented soybeans with Bacillus amyloliquefaciens potentiated insulin secretion capacity and improved gut microbiome diversity and intestinal integrity to alleviate Asian type 2 diabetic symptoms" 68 : 13168-13178, 2020
• 8 Tsugawa H, "Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis" 112 : 292-298, 2011
• 9 Kim IS, "Physiologically active molecules and functional properties of soybeans in human health-A current perspective" 22 : 4054-, 2021
• 10 Monk JM, "Navy bean supplemented high-fat diet improves intestinal health, epithelial barrier integrity and critical aspects of the obese inflammatory phenotype" 70 : 91-104, 2019
• 11 Grondin JA, "Mucins in intestinal mucosal defense and inflammation : learning from clinical and experimental studies" 11 : 2054-, 2020
• 12 Lommen A, "MetAlign : interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing" 81 : 3079-3086, 2009
• 13 de Vos WM, "Gut microbiome and health : mechanistic insights" 71 : 1020-1032, 2022
• 14 Squadrito F, "Genistein in the metabolic syndrome : results of a randomized clinical trial" 98 : 3366-3374, 2013
• 15 Muller M, "Gastrointestinal transit time, glucose homeostasis and metabolic health : Modulation by dietary fibers" 10 : 275-, 2018
• 16 do Prado FG, "Fermented soy products and their potential health benefits : A review" 10 : 1606-, 2022
• 17 Ashaolu TJ, "Fermentation of prebiotics by human colonic microbiota in vitro and short-chain fatty acids production : a critical review" 130 : 677-687, 2021
• 18 Lattimer JM, "Effects of dietary fiber and its components on metabolic health" 2 : 1266-1289, 2010
• 19 Khoshbin K, "Effects of dietary components on intestinal permeability in health and disease" 319 : G589-G608, 2020
• 20 Kim JH, "Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat" 97 : 124-131, 2005
• 21 Nagata C, "Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults : the Takayama study" 105 : 426-431, 2017
• 22 Gaman L, "Can ageing be slowed? : Hormetic and redox perspectives" 4 : 346-351, 2011
• 23 Carmona JJ, "Biology of healthy aging and longevity" 68 : 7-16, 2016
• 24 Cao ZH, "Bioactivity of soy-based fermented foods : A review" 37 : 223-238, 2019
• 25 김소연 ; 이경복 ; 조영호 ; 정도연 ; 양희종 ; 류명선 ; 유영춘, "Bacillus amyloliquefaciens SCGB 1 발효 청국장 추출물에 의한 항염증 활성 및 염증성 질환 억제 효과" 한국식품영양과학회 49 (49): 659-667, 2020
• 26 Kanwal S, "Attenuation of DSS induced colitis by Dictyophora indusiata polysaccharide(DIP)via modulation of gut microbiota and inflammatory related signaling pathways" 64 : 103641-, 2020
• 27 Shahbazi R, "Anti-inflammatory and immunomodulatory properties of fermented plant foods" 13 : 1516-, 2021
• 28 홍선화 ; 황성우 ; 양희종 ; 정도연 ; 김옥진, "Anti-atopic dermatitis effect of the soybean fermented by B. amyloliquefaciens via inhibiting IL-31" 동물의학연구소 20 (20): 30-36, 2019
• 29 Silva S, "An overview about oxidation in clinical practice of skin aging" 92 : 367-374, 2017
• 30 Kurosawa Y, "A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles" 5 : 11601-, 2015